Agree Steve.
Doubled my holding as well .....thanks to all the sellers.
Last year the whinging was about no licenses signed, no revenue, no BG, no other partner and the coy was smoke and mirrors.
So far we have:
1. Master license Agreement with P&G
2. Two license term sheets executed W1andW2
3. W3&4 committed to follow
4. Revenue flowing with two branded W1 launches
5. w2 a month of so till launch
5. Potentially P&G about to sign major agreement on Personalisation
6. Various other live product discussions advancing on the BG front and Surface Hygiene etc....
7. Very real chance of being cashflow positive this calendar year and after that profit and returns
8. There has been allot of company talk about Pfizer and VMS and these things take time just like with P&G 3 years ago to now.
All this has been outlined in the recent updates
OBJ is monetising its technologies
Why do various people think this is not happening when it is happening.
There are real logistics in coordinating product supply with demand in various markets that is why markets are being drip fed. This is my take not confirmed but seems logical to me.
Time to have a cup of tie and relax.
- Forums
- ASX - By Stock
- WFL
- the crowd maybe wrong
WFL
wellfully limited
Add to My Watchlist
0.00%
!
0.3¢

the crowd maybe wrong, page-9
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
0.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $1.478M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
WFL (ASX) Chart |
Day chart unavailable
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Dr Michael Thurn, CEO & MD
Dr Michael Thurn
CEO & MD
SPONSORED BY The Market Online